These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35836930)

  • 1. Tumor Microenvironment Heterogeneity-Based Score System Predicts Clinical Prognosis and Response to Immune Checkpoint Blockade in Multiple Colorectal Cancer Cohorts.
    Wang H; Li Z; Ou S; Song Y; Luo K; Guan Z; Zhao L; Huang R; Yu S
    Front Mol Biosci; 2022; 9():884839. PubMed ID: 35836930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive multi-omics analysis identifies a robust scoring system for cancer-associated fibroblasts and intervention targets in colorectal cancer.
    Wang F; Li Z; Xu T; Zhang Q; Ma T; Li S; Wang X
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):124. PubMed ID: 38478111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bioinformatics-based immune-related prognostic index for lung adenocarcinoma that predicts patient response to immunotherapy and common treatments.
    Wang C; Lu T; Xu R; Chang X; Luo S; Peng B; Wang J; Yao L; Wang K; Shen Z; Zhao J; Zhang L
    J Thorac Dis; 2022 Jun; 14(6):2131-2146. PubMed ID: 35813746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-Omics Analysis Reveals Intratumor Microbes as Immunomodulators in Colorectal Cancer.
    Liu Z; Zhang X; Zhang H; Zhang H; Yi Z; Zhang Q; Liu Q; Liu X
    Microbiol Spectr; 2023 Feb; 11(2):e0503822. PubMed ID: 36786568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment characterization in colorectal cancer to identify prognostic and immunotherapy genes signature.
    Guo XW; Lei RE; Zhou QN; Zhang G; Hu BL; Liang YX
    BMC Cancer; 2023 Aug; 23(1):773. PubMed ID: 37596528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 7. A Novel Immune Gene-Related Prognostic Score Predicts Survival and Immunotherapy Response in Glioma.
    Luo X; Wang Q; Tang H; Chen Y; Li X; Chen J; Zhang X; Li Y; Sun J; Han S
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676646
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of endoplasmic reticulum stress unveils ZNF703 as a promising target for colorectal cancer immunotherapy.
    Wang H; Li Z; Tao Y; Ou S; Ye J; Ran S; Luo K; Guan Z; Xiang J; Yan G; Wang Y; Ma T; Yu S; Song Y; Huang R
    J Transl Med; 2023 Oct; 21(1):713. PubMed ID: 37821882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
    Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
    Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conserved angio-immune subtypes of the tumor microenvironment predict response to immune checkpoint blockade therapy.
    Subramanian M; Kabir AU; Barisas D; Krchma K; Choi K
    Cell Rep Med; 2023 Jan; 4(1):100896. PubMed ID: 36630952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL5 as a Prognostic Marker for Survival and an Indicator for Immune Checkpoint Therapies in Small Cell Lung Cancer.
    Tang Y; Hu Y; Niu Y; Sun L; Guo L
    Front Med (Lausanne); 2022; 9():834725. PubMed ID: 35252266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model.
    Zheng K; Hai Y; Chen H; Zhang Y; Hu X; Ni K
    J Transl Med; 2024 Apr; 22(1):365. PubMed ID: 38632658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting prognosis and clinical efficacy of immune checkpoint blockade therapy
    Fan B; Zheng X; Wang Y; Hu X
    Pathol Oncol Res; 2023; 29():1611117. PubMed ID: 37082269
    [No Abstract]   [Full Text] [Related]  

  • 14. The Effects of Differentially-Expressed Homeobox Family Genes on the Prognosis and HOXC6 on Immune Microenvironment Orchestration in Colorectal Cancer.
    Qi L; Ye C; Zhang D; Bai R; Zheng S; Hu W; Yuan Y
    Front Immunol; 2021; 12():781221. PubMed ID: 34950145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conserved immuno-collagenic subtypes predict response to immune checkpoint blockade.
    Mei J; Cai Y; Xu R; Li Q; Chu J; Luo Z; Sun Y; Shi Y; Xu J; Li D; Liang S; Jiang Y; Liu J; Qian Z; Zhou J; Wan M; Yang Y; Zhu Y; Zhang Y; Yin Y
    Cancer Commun (Lond); 2024 May; 44(5):554-575. PubMed ID: 38507505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-infiltrating signature-based classification reveals CD103
    Luo Y; Zong Y; Hua H; Gong M; Peng Q; Li C; Neculai D; Zeng X
    Front Immunol; 2022; 13():1011590. PubMed ID: 36311750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade.
    Sun B; Xun Z; Zhang N; Liu K; Chen X; Zhao H
    Cancer Cell Int; 2023 Dec; 23(1):313. PubMed ID: 38066642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a T-cell activation-related module with predictive value for the prognosis and immune checkpoint blockade therapy response in glioblastoma.
    Yan Z; Chu S; Zhu C; Han Y; Liang Q; Shen S; Cheng W; Wu A
    PeerJ; 2021; 9():e12547. PubMed ID: 35036121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reclassifying TNM stage I/II colorectal cancer into two subgroups with different overall survival, tumor microenvironment, and response to immune checkpoint blockade treatment.
    Liu X; Qin J; Nie J; Sun H; Pan Y; Wang S
    Front Genet; 2022; 13():948920. PubMed ID: 36212126
    [No Abstract]   [Full Text] [Related]  

  • 20. Single-cell dissection reveals the role of DNA damage response patterns in tumor microenvironment components contributing to colorectal cancer progression and immunotherapy.
    Shen X; Mo S; Wang Y; Lin L; Liu Y; Weng M; Gu W; Nakajima T
    Genes Cells; 2023 May; 28(5):348-363. PubMed ID: 36811212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.